Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a
{{output}}
CD4+ T cells with latent HIV-1 infection persist despite treatment with antiretroviral agents and represent the main barrier to a cure of HIV-1 infection. Pharmacological disruption of viral latency may expose HIV-1-infected cells to host immune activity, but ... ...
